(Q56751306)

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Screening for lung cancer. The Mayo Lung Project revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Airways obstruction and the risk for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Differences in lung cancer risk between men and women: examination of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Clinical applications of serum markers for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Histopathologic classification of small cell lung cancer. Changing concepts and terminology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

A randomized trial of surgery in the treatment of single metastases to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Cost-effectiveness of Head CT in Patients With Lung Cancer Without Clinical Evidence of Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Diagnostic value of bronchoalveolar lavage in peripheral lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Approach to the solitary pulmonary nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

The utility of fiberoptic bronchoscopy in the evaluation of the solitary pulmonary nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

CT evaluation of solitary pulmonary nodules: value of 185-H reference phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Thoracoscopy for the diagnosis of pleural disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Preoperative pulmonary function testing for patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Preoperative assessment as a predictor of mortality and morbidity after lung resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Assessment of exercise oxygen consumption as preoperative criterion for lung resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.1.ATS156.1